Bayer making compound for incubator client; Investment will help Azelis go global;

> Bayer HealthCare will handle the preclinical manufacturing of a compound for Aronora, a tenant of Bayer's U.S. CoLaborator incubator facility in San Francisco. Release

> Apax Partners will buy a majority stake in Azelis from 3i Group for an undisclosed sum, an investment that will help the European chemical distributor expand globally. Story

> A German team says continuous manufacturing could lower the cost of making the API efaverinz used in an HIV drug. Report

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.